Owlet

Owlet, Inc. is a digital parenting platform, which engages in the provision of real-time data and insights, and parenting solutions. The firm is engaged in developing and marketing its products and content for children. It offers the Owlet BabySat, Owlet OTC Smart Sock, and Owlet Band products that allow the sharing of infant sleep and health data, and also provides an end-to-end digital healthcare solution for its customers. The company was founded by Kurt Workman, Zack Bomsta, Jordan Monroe, and Jake Colvin in 2013 and is headquartered in Lehi, UT.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Owlet reports robust Q1 earnings, eyes European expansion and new products

Owlet's Q1 2024 earnings call highlighted strong financial performance, strategic growth initiatives, and a focus on maximizing growth and profitability. With a solid cash position, positive market response to products, and a clear growth plan, Owlet is well-positioned for success in the infant health technology market.

Owlet reports robust Q2 earnings, eyes pediatric health platform growth

Owlet's Q2 2024 performance showcased strong revenue growth, positive adjusted EBITDA, and strategic product launches. The company's focus on infant health information and pediatric health platform transition positions it well for future growth. Addressing challenges and seizing opportunities will be key for Owlet's continued success.

Owlet reports robust Q3 performance, eyes global expansion and profitability

Owlet's Q3 2024 earnings call highlighted strong revenue growth, key achievements in product clearances and sales events, and a focus on profitability and sustainable growth.
While facing challenges with operating and net losses, the company showcased resilience through innovation, global expansion, and commitment to cost management.
With a positive outlook for 2025, Owlet aims to capitalize on growth opportunities, address challenges in profitability, and drive sustainable expansion in the market.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces that it has filed a class action lawsuit in the United States District Court for the Central District of California captioned Butala v. Owlet, Inc., et al., (Case No. 21-cv-09016) on behalf of persons and entities (a) that purchased or otherwise acquired Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) securities between March 31, 2021 and October 4, 2021, inclusive (the “Class Period”); and/or (b) held Sandbridg

OWLT CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Owlet, Inc.

NEW YORK--(BUSINESS WIRE)---- $OWLT--The law firm of Kirby McInerney LLP is investigating potential claims against Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT). The investigation concerns whether Owlet has violated the federal securities laws and/or engaged in other unlawful business practices. On October 4, 2021, Owlet disclosed that it had received a warning letter from the U.S. Food and Drug Administration (“FDA”), which stated that “the Company's marketing of its Owlet Smart Sock product . . .

INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of Owlet, Inc. (OWLT) Investors

Los Angeles, California--(Newsfile Corp. - November 12, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owlet, Inc. ("Owlet" or "the Company") (NYSE: OWLT) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Owlet disclosed on October 4, 2021, that it received a warning letter...

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Owlet, Inc. and Encourages Investors with Losses to Contact the Firm

Owlet, Inc. (OWLT) CEO Kurt Workman on Q3 2021 Results - Earnings Call Transcript

LEHI, Utah--(BUSINESS WIRE)--Owlet Announces Third Quarter 2021 Financial Results

Owlet Announces Third Quarter 2021 Financial Results

NEW YORK, Nov. 4, 2021 /PRNewswire/ --  Wolf Haldenstein Adler Freeman & Herz LLP is LLC is investigating whether Owlet, Inc. ("OWLT or the "Company") (NYSE: OWLT) complied with federal securities laws. On October 4, 2021, the Company disclosed through an SEC filing that it received a warning letter from the FDA.

OWLET, INC. INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Owlet, Inc.

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, is investigating whether Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) and certain of its officers and directors violated federal securities laws by making materially misleading statements to investors. If you purchased or otherwise own Owlet stock, and have suffered a loss, you are encouraged to contact Scott+Scott attorney, Rhiana Swartz, at rswa

Scott+Scott Attorneys at Law LLP Announces Investigation into Owlet, Inc. (OWLT)

LOS ANGELES, Oct. 20, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM"), a national investor rights law firm, continues its investigation on behalf of Owlet, Inc.  ("Owlet" or the "Company") (NYSE: OWLT) investors concerning the Company and its officers' possible violations of the federal securities laws.   If you suffered a loss on your Owlet investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/owlet-inc/.You can also contact Charles H.

Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Owlet, Inc. (OWLT) on Behalf of Investors

BENSALEM, Pa., Oct. 20, 2021 /PRNewswire/ -- Law Offices of Howard G.

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Owlet, Inc. (OWLT) on Behalf of Investors

NEW YORK, Oct. 15, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Owlet, Inc. ("Owlet" or the "Company") (NYSE: OWLT). Such investors are advised to contact Robert S.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Owlet, Inc. - OWLT

Boston, Massachusetts--(Newsfile Corp. - October 14, 2021) - The Thornton Law Firm alerts investors that it is investigating Owlet, Inc. (NYSE: OWLT) for potential securities violations. Investors who currently own shares or options of OWLT may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Owlet for more information. Investors may also email investors@tenlaw.com or call 617-531-3917. FOR MORE INFORMATION: www.tenlaw.com/cases/OwletOn October 4, 2021, Owlet, Inc. stock fell more than 30% after notifying investors...

OWLT INVESTOR ALERT: Thornton Law Firm Announces Investigation

San Francisco, California--(Newsfile Corp. - October 13, 2021) -  Hagens Berman urges Owlet, Inc. (NYSE: OWLT) investors with significant losses to submit your losses now.Visit: www.hbsslaw.com/investor-fraud/OWLT Contact An Attorney Now: OWLT@hbsslaw.com 844-916-0895Owlet, Inc. (OWLT) Investigation: The firm's investigation focuses on Owlet's claims about its in-home pediatric monitoring and analytics technologies which are intended to detect infant ailments such as respiratory syncytial virus and supraventricular tachycardia and,

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Owlet, Inc. (OWLT) Investors to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations

Boston, Massachusetts--(Newsfile Corp. - October 12, 2021) - Block & Leviton is investigating Owlet, Inc. (NYSE: OWLT) for potential securities law violations. Investors who have lost money in their Owlet, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/owlt.What is this all about?Earlier today, Owlet Inc. announced that it had received a warning letter from the FDA asserting that Owlet's marketing of its...

OWLET INVESTIGATION: Block & Leviton Is Investigating Owlet, Inc. For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

RADNOR, Pa.--(BUSINESS WIRE)---- $OWLT--Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Owlet, Inc. (NYSE: OWLT) Investors

OWLT Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Owlet, Inc. (NYSE: OWLT) Investors

LEHI, Utah--(BUSINESS WIRE)--Owlet to Report Third Quarter 2021 Results on November 10, 2021

Owlet to Report Third Quarter 2021 Results on November 10, 2021

NEW YORK, Oct. 6, 2021 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Owlet, Inc. (NYSE: OWLT) resulting from allegations that Owlet may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Owlet securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Owlet, Inc. Investors to Inquire About Class Action Investigation - OWLT

LOS ANGELES, Oct. 6, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owlet, Inc. ("Owlet" or "the Company") (NYSE: OWLT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Owlet, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $OWLT #investors--The Law Offices of Frank R. Cruz Continues Investigation of Owlet, Inc. (OWLT) on Behalf of Investors

The Law Offices of Frank R. Cruz Continues Investigation of Owlet, Inc. (OWLT) on Behalf of Investors

SAN DIEGO, Oct. 5, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Owlet, Inc. (NASDAQ: OWLT). On October 4, 2021, Owlet disclosed it received a Warning Letter from the U.S. Food and Drug Administration (FDA) regarding the Owlet Smart Sock.

(OWLT) Alert: Did You Lose Money on Your Owlet Investment? Contact Johnson Fistel Regarding Investigation

LOS ANGELES--(BUSINESS WIRE)---- $OWLT #OWLT--INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Owlet, Inc.

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Owlet, Inc. and Encourages Investors with Losses to Contact the Firm

SAN FRANCISCO, Oct. 5, 2021 /PRNewswire/ -- Hagens Berman urges Owlet, Inc. (NYSE: OWLT) investors with significant losses to submit your losses now.  Visit: www.hbsslaw.com/investor-fraud/OWLT Contact An Attorney Now: OWLT@hbsslaw.com 844-916-0895 Owlet, Inc. (OWLT) Investigation: The firm's investigation focuses on Owlet's claims about its in-home pediatric monitoring and analytics technologies which are intended to detect infant ailments such as respiratory syncytial virus and supraventricular tachycardia and, thereby, decrease infant death due to Sudden Unexplained Infant Death and Sudden Infant Death Syndrome.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Owlet, Inc. (OWLT) Investors to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations

MILWAUKEE, Oct. 5, 2021 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Owlet (NYSE: OWLT). The investigation results from inaccurate statements Owlet may have made regarding its business operations and prospects.

Ademi LLP Investigates Claims of Securities Fraud against Owlet, Inc.

A warning letter from the FDA is never a good sign for a company like Owlet.

Why Owlet Stock Plunged 31.3% Today

LOS ANGELES--(BUSINESS WIRE)---- $OWLT #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Owlet investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can s

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Owlet, Inc. (OWLT) on Behalf of Investors

Owlet Inc (NYSE: OWLT) stock has dropped almost 24% in the trading session due to receiving a Warning Letter dated October 1, 2021, from the FDA. The Warning Letter asserts that the Company's marketing of its Owlet Smart Sock product in the U.S. renders the Smart Sock a medical device requiring premarket clearance or approval from FDA.

News for Owlet Stock (OWLT)